BioStem Technologies to Present at the Fall Foliage MicroCap Rodeo Conference

October 18, 2023

POMPANO BEACH, FL / October 18, 2023 / BioStem Technologies Inc. (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, will present at the 2023 virtual Fall Foliage MicroCap Rodeo Conference to be held from October 24th - 27th.

Jason Matuszewski, Chief Executive Officer of BioStem, said, "BioStem has achieved a number of significant milestones in 2023, including the strategic acquisition of Auxocell Laboratories' assets and securing an agreement with NovaBay Pharmaceuticals to commercialize our amniotic tissue allograft under the Avenova® Allograft brand for ocular surface repair. With our newly formed partnership with Lovell® Government Services, we are also pleased to have been listed on key government contract vehicles for the Department of Defense and the Department of Veteran Affairs.

"In September 2023, we announced the nationwide launch of AmnioWrap2TM in collaboration with leading US wound market solutions provider, Venture Medical, LLC. The same month we received Independent Review Board approval for a clinical study evaluating our Vendaje product for Diabetic Foot Ulcers (DFU) and we expect to initiate this study before year-end.

"My colleagues and I look forward to sharing these numerous achievements, how they are positioning us for success, and our forward-looking strategy to continue our growth trajectory into 2024 and beyond with investors at the MicroCap Rodeo," said Mr. Matuszewski.

The presentation will begin at 9:00 ET on Wednesday, October 25. To register to attend and access the presentation, please visit

Subscribe To Our Newsletter

To stay up to date on all of our news, products, and achievements, please subscribe to our newsletter

Contact Information
(954) 380-8342

2836 Center Port Circle
Pompano Beach, FL 33064




© 2021 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.
For screen reader problems with this website, please call (954) 380-8342 for assistance.